Oklahoma City

NANETS Regional NET Education: Multidisciplinary Management of NET Cancers

The Oklahoma City NANETS Regional NET Education Conference will take place on Saturday, November 18, 2017 at the Stephenson Cancer Center, 800 NE 10th St, Oklahoma City, OK 73104. Check-in is at 7:30 am, and the final session is scheduled to conclude at 3:50 pm.

This comprehensive, one-day program is offered in conjunction with The Oklahoma University. It will provide multidisciplinary training to medical professionals in Oklahoma. Local physicians and allied healthcare providers come together with leaders in neuroendocrine medicine to educate and discuss NET disease and patient care. Participants will learn about standard management of patients with neuroendocrine tumors, as well as new diagnostic and therapeutic techniques.

Program

 

Location

Stephenson Cancer Center
800 NE 10th Street
Oklahoma City, OK 73104 

Registration

Registration is now open!  Please click here to register on the CME provider website. 

Area Hotels

Embassy Suites Oklahoma City Downtown Medical Center (0.2 miles from Stephenson Cancer Center)
741 N Phillips Avenue
Oklahoma City, OK 73104
(405) 239-3900

SpringHill Suites by Marriott Oklahoma City Downtown/Bricktown (1.1 miles from Stephenson Cancer Center)
600 E Sheridan Avenue
Oklahoma City, OK 73104
(405) 601-6206

Aloft Oklahoma City Downtown - Bricktown (1.2 miles from Stephenson Cancer Center)
209 N Walnut Avenue
Oklahoma City, OK 73104
(405) 605-2100

Questions?

Please call or email NANETS headquarters, 650-762-6387, staff@NANETS.net with any questions.

Support Opportunities

Download and view our Oklahoma NANETS Regional NET Education Support Prospectus to see all support opportunities for this event. To discuss supporting this event, please call or email NANETS headquarters, 650-762-6387, staff@NANETS.net

CME

The University of Oklahoma College of Medicine: Office Of Continuing Professional Development is the CME for this conference.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Oklahoma College of Medicine and the North American Neuroendocrine Tumor Society. The University of Oklahoma College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict Resolution Statement:

The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.

Activity Description, Purpose and Intended/Target Audience:

Activity Description: Through this CME activity we will go over epidemiology, presentation, diagnostic modalities and different medical and surgical approaches to NETs. Updates will be given as well as an overview of all available clinical trials.

Intended/Target Audience:  Primary care physicians including general medicine, specialty physicians including oncology, radiology, nuclear medicine, endocrinology, gastroenterology, and pulmonology, physician assistants, nurses, and nurse practitioners.

Planning Committee Members:

  • Hassan Hatoum, MD - Course Director
  • Jamie Mowers, MPH, MSW, MS - Course Contact
  • Renuka Iyer, MD
  • Thorvardur Halfdanarson, MD
  • Brigitte Connors-Mare
  • Stevie Warner, MHR
  • Claire Turmelle, BA

Learning Objectives:  Upon completion of this activity, participants will improve their competence and performance by being able to:

  • Discuss updates in diagnostic modalities in neuroendocrine tumors (NETs).
  • Identify the use of different treatment approaches in combination or in sequence based on disease burden and symptomology.

Nondiscrimination Statement:

The University of Oklahoma, in compliance with all applicable federal and state laws and regulations does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, and educational services.

The University of Oklahoma is an equal opportunity institution. www.ou.edu/eoo.

Accommodation Statement

Accommodations on the basis of disability are available by contacting Stevie Warner at (405) 271- 2537 or stevie-warner@ouhsc.edu  OR Jamie Mowers at (650) 762-6387 or staff@nanets.net as soon as possible.

Acknowledgement of Commercial and In-Kind Support

Commercial support is financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of a CME activity.  A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.

Disclaimer Statement:

Statements, opinions and results of studies contained in the program are those of the presenters, authors and joint provider and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty, Joint Provider and Presenters Disclosure

It is the policy of the University of Oklahoma, College of Medicine that the faculty, presenters and joint provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).